These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19834686)

  • 1. The V16A polymorphism in SOD2 is associated with increased risk of diabetic nephropathy and cardiovascular disease in type 1 diabetes.
    Möllsten A; Jorsal A; Lajer M; Vionnet N; Tarnow L
    Diabetologia; 2009 Dec; 52(12):2590-3. PubMed ID: 19834686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functional polymorphism in the manganese superoxide dismutase gene and diabetic nephropathy.
    Möllsten A; Marklund SL; Wessman M; Svensson M; Forsblom C; Parkkonen M; Brismar K; Groop PH; Dahlquist G
    Diabetes; 2007 Jan; 56(1):265-9. PubMed ID: 17192491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endothelial nitric oxide synthase gene and risk of diabetic nephropathy and development of cardiovascular disease in type 1 diabetes.
    Möllsten A; Lajer M; Jorsal A; Tarnow L
    Mol Genet Metab; 2009 May; 97(1):80-4. PubMed ID: 19246226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The manganese superoxide dismutase Val16Ala polymorphism is associated with decreased risk of diabetic nephropathy in Chinese patients with type 2 diabetes.
    Liu L; Zheng T; Wang N; Wang F; Li M; Jiang J; Zhao R; Li L; Zhao W; Zhu Q; Jia W
    Mol Cell Biochem; 2009 Feb; 322(1-2):87-91. PubMed ID: 18989629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manganese superoxide dismutase gene polymorphism (V16A) is associated with stages of albuminuria in Korean type 2 diabetic patients.
    Lee SJ; Choi MG; Kim DS; Kim TW
    Metabolism; 2006 Jan; 55(1):1-7. PubMed ID: 16324912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
    Agardh CD; Agardh E; Torffvit O
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Good glycemic control remains crucial in prevention of late diabetic complications--the Linköping Diabetes Complications Study.
    Nordwall M; Arnqvist HJ; Bojestig M; Ludvigsson J
    Pediatr Diabetes; 2009 May; 10(3):168-76. PubMed ID: 19175900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manganese superoxide dismutase (SOD2) polymorphisms, plasma advanced oxidation protein products (AOPP) concentration and risk of kidney complications in subjects with type 1 diabetes.
    Mohammedi K; Bellili-Muñoz N; Driss F; Roussel R; Seta N; Fumeron F; Hadjadj S; Marre M; Velho G
    PLoS One; 2014; 9(5):e96916. PubMed ID: 24819633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy.
    Theilade S; Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
    Diabet Med; 2012 Mar; 29(3):337-44. PubMed ID: 21988672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of +35A/C (intron3/exon3) polymorphism in SOD1-gene with diabetic nephropathy in type 1 diabetes.
    Panduru NM; Cimponeriu D; Cruce M; Ion DA; Moţa E; Moţa M; Serafinceanu C; Chivu LI; Panduru M; Chivu RD; Covic AC
    Rom J Morphol Embryol; 2010; 51(1):37-41. PubMed ID: 20191117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes.
    Wadén J; Forsblom C; Thorn LM; Gordin D; Saraheimo M; Groop PH;
    Diabetes; 2009 Nov; 58(11):2649-55. PubMed ID: 19651819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy.
    Tarnow L; Cambien F; Rossing P; Nielsen FS; Hansen BV; Lecerf L; Poirier O; Danilov S; Boelskifte S; Borch-Johnsen K
    Diabetologia; 1995 Jul; 38(7):798-803. PubMed ID: 7556981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
    Lajer M; Tarnow L; Jorsal A; Teerlink T; Parving HH; Rossing P
    Diabetes Care; 2008 Apr; 31(4):747-52. PubMed ID: 18162497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies.
    Hadjadj S; Fumeron F; Roussel R; Saulnier PJ; Gallois Y; Ankotche A; Travert F; Abi Khalil C; Miot A; Alhenc-Gelas F; Lievre M; Marre M; ; ;
    Diabetes Care; 2008 Sep; 31(9):1847-52. PubMed ID: 18523145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort.
    Klein RL; Hunter SJ; Jenkins AJ; Zheng D; Semler AJ; Clore J; Garvey WT;
    Diabetes Care; 2003 May; 26(5):1439-48. PubMed ID: 12716802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphism of renin-angiotensin system is not associated with diabetic vascular complications in Japanese subjects with long-term insulin dependent diabetes mellitus.
    Miura J; Uchigata Y; Yokoyama H; Omori Y; Iwamoto Y
    Diabetes Res Clin Pract; 1999 Aug; 45(1):41-9. PubMed ID: 10499884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of catalase gene promoter in Romanian patients with diabetic kidney disease and type 1 diabetes.
    Panduru NM; Moţa E; Moţa M; Cimponeriu D; Serafinceanu C; Cheţa DM
    Rom J Intern Med; 2010; 48(1):81-8. PubMed ID: 21180245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone synthase (CYP11B2) -344T/C polymorphism is not associated with the initiation and progression of diabetic nephropathy in Caucasian Type 1 diabetic patients.
    Lajer M; Schjoedt KJ; Jacobsen P; Tarnow L; Parving HH
    Diabet Med; 2006 Jun; 23(6):675-80. PubMed ID: 16759311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes.
    Patente TA; Mohammedi K; Bellili-Muñoz N; Driss F; Sanchez M; Fumeron F; Roussel R; Hadjadj S; Corrêa-Giannella ML; Marre M; Velho G
    Free Radic Biol Med; 2015 Sep; 86():16-24. PubMed ID: 25862415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of parental risk factors on the risk of stroke in type 1 diabetes.
    Ylinen A; Hägg-Holmberg S; Eriksson MI; Forsblom C; Harjutsalo V; Putaala J; Groop PH; Thorn LM;
    Acta Diabetol; 2021 Jul; 58(7):911-917. PubMed ID: 33721078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.